SCHEMBL30333558

SCHEMBL30333558

[2H]c1cc(-c2ccc3ncnc(N4CCNCC4)c3c2)cnc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 16/20 0.64
CYP3A4 P08684 16/20 0.64
CLK4 Q9HAZ1 12/20 0.64
CYP2C19 P33261 10/20 0.64
USP2 O75604 7/20 0.64
HSD17B10 Q99714 4/20 0.64
KDM4E B2RXH2 4/20 0.61
ALDH1A1 P00352 8/20 0.60
CYP2D6 P10635 7/20 0.59
HPGD P15428 3/20 0.59
MAPT P10636 2/20 0.59
LMNA P02545 9/20 0.55
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
TSHR P16473 4/20 0.54
HTT P42858 1/20 0.52
MAPK1 P28482 5/20 0.52
HIF1A Q16665 4/20 0.49
PIK3CD O00329 1/20 0.49
PIK3CA P42336 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30333672 0.92 CYP1A2 (0.53) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333730 0.87 CYP1A2 (0.49) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333371 0.86 CYP1A2 (0.47) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30334425 0.85 CYP1A2 (0.50) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333230 0.84 CYP1A2 (0.46) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30332986 0.84 CYP1A2 (0.46) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333415 0.80 PIK3CD (0.53) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333432 0.80 PIK3CD (0.58) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30334606 0.79 CYP1A2 (0.55) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL183522 0.76 PIK3CD (0.52) CYP1A2CYP3A4CLK4CYP2C19USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023045960-A1 PYRIDINE DERIVATIVE AND USE THEREOF 四川汇宇制药股份有限公司 2023-03-30 WO disclosed